Skip to main content
Top
Published in: International Ophthalmology 2-3/2007

01-06-2007 | Original Paper

Vogt–Koyanagi–Harada disease in Hispanic patients

Authors: Somsiri Sukavatcharin, Julie H. Tsai, Narsing A. Rao

Published in: International Ophthalmology | Issue 2-3/2007

Login to get access

Abstract

Purpose

To describe the clinical features of Vogt–Koyanagi–Harada disease (VKH) in Hispanic patients.

Methods

Retrospective review of the records of 48 Hispanic patients diagnosed with VKH. The patients were divided into two groups: patients in the early phase of VKH (n = 11) were those who presented within 1 month after the onset of symptoms; patients in the late or chronic VKH phase (n = 37) were those who presented 6 months after onset of symptoms. Demographic data, clinical features, complications and initial and final visual acuity for each patient were recorded.

Results

All 11 patients in early phase VKH presented with bilateral uveitis (100%). Meningismus was noted in six cases and auditory disturbances in three. Ocular findings for these 11 patients included exudative retinal detachment in ten patients (91%) and marked optic disc edema in one patient. In the late phase VKH, ocular findings included sunset glow fundus in 26 patients (70%), peripheral nummular scars in 27 (73%), and retinal pigment epithelium hyperplasia in seven (19%). Extraocular manifestations noted in this group of patients included vitiligo in four, poliosis in six, and alopecia in five; auditory disturbances were found in four patients. The visual acuity improved in 60–70% of the patients after treatment with corticosteroids alone or in combination with immunosuppressive agents.

Conclusion

Hispanic patients with VKH often present without extraocular changes during early phase of the disease. However, once the disease evolves into the chronic phase, integumentary system involvement may become apparent in some patients.
Literature
1.
go back to reference Moorthy RS, Inomata H, Rao NA (1995) Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol 39:265–292PubMedCrossRef Moorthy RS, Inomata H, Rao NA (1995) Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol 39:265–292PubMedCrossRef
2.
go back to reference Sugiura S (1978) Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol 22:9–35 Sugiura S (1978) Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol 22:9–35
3.
go back to reference Alaez C, del Pilar Mora M, Arellanes L, Cano S, Perez-Luque E, Vazquez MN, et al. 1999 Strong association of HLA class II sequences in Mexicans with Vogt–Koyanagi–Harada’s disease. Hum Immunol 60:875–882PubMedCrossRef Alaez C, del Pilar Mora M, Arellanes L, Cano S, Perez-Luque E, Vazquez MN, et al. 1999 Strong association of HLA class II sequences in Mexicans with Vogt–Koyanagi–Harada’s disease. Hum Immunol 60:875–882PubMedCrossRef
4.
go back to reference Levinson RD, See RF, Rajalingam R, Reed EF, Park MS, Rao NA, et al. (2004) HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt–Koyanagi–Harada’s disease in Southern California. Hum Immunol 65:1477–1482PubMedCrossRef Levinson RD, See RF, Rajalingam R, Reed EF, Park MS, Rao NA, et al. (2004) HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt–Koyanagi–Harada’s disease in Southern California. Hum Immunol 65:1477–1482PubMedCrossRef
5.
go back to reference Shimizu K (1973) Harada’s, Behcet’s, Vogt–Koyanagi syndromes−are they clinical entities? Trans Am Acad Ophthalmol Otolarnyngol 77:OP281–OP290 Shimizu K (1973) Harada’s, Behcet’s, Vogt–Koyanagi syndromes−are they clinical entities? Trans Am Acad Ophthalmol Otolarnyngol 77:OP281–OP290
6.
go back to reference Ohno S, Char DH, Kimura SJ, O’Connor GR (1977) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 83:735–740PubMed Ohno S, Char DH, Kimura SJ, O’Connor GR (1977) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 83:735–740PubMed
7.
go back to reference Snyder DA, Tessler HH (1980) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 90:69–75PubMed Snyder DA, Tessler HH (1980) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 90:69–75PubMed
8.
go back to reference Nussenblatt RB (1988) Clinical studies of Vogt–Koyanagi–Harada’s disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 32:330–333PubMed Nussenblatt RB (1988) Clinical studies of Vogt–Koyanagi–Harada’s disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 32:330–333PubMed
9.
go back to reference Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA (1991) Variations in clinical features of the Vogt–Koyanagi–Harada syndrome. Retina 11:275–280PubMedCrossRef Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA (1991) Variations in clinical features of the Vogt–Koyanagi–Harada syndrome. Retina 11:275–280PubMedCrossRef
10.
go back to reference Rosen E (1945) Uveitis, with poliosis, vitiligo, alopecia and dysacusia (Vogt–Koyanagi syndrome). Arch Ophthalmol 33:281–292 Rosen E (1945) Uveitis, with poliosis, vitiligo, alopecia and dysacusia (Vogt–Koyanagi syndrome). Arch Ophthalmol 33:281–292
11.
go back to reference Minakawa R, Ohno S, Hirose S, Kotake S, Miyajima T, Tagawa Y, et al. (1985) Clinical manifestation of Vogt–Koyanagi–Harada’s disease. Jpn J Clin Ophthalmol 39:1249–1253 Minakawa R, Ohno S, Hirose S, Kotake S, Miyajima T, Tagawa Y, et al. (1985) Clinical manifestation of Vogt–Koyanagi–Harada’s disease. Jpn J Clin Ophthalmol 39:1249–1253
12.
go back to reference Ohno S, Minakawa R, Matsuda H (1988) Clinical studies of Vogt–Koyanagi–Harada’s disease. Jpn J Ophthalmol 32:334–343PubMed Ohno S, Minakawa R, Matsuda H (1988) Clinical studies of Vogt–Koyanagi–Harada’s disease. Jpn J Ophthalmol 32:334–343PubMed
13.
go back to reference Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652PubMedCrossRef Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652PubMedCrossRef
14.
go back to reference Bouchenaki N, Herbort CP (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt–Koyanagi–Harada disease. Ophthalmology 108:54–64PubMedCrossRef Bouchenaki N, Herbort CP (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt–Koyanagi–Harada disease. Ophthalmology 108:54–64PubMedCrossRef
15.
go back to reference Rutzen AR, Ortega-Larrocea G, Frambach DA, Rao NA (1995) Macular edema in chronic Vogt–Koyanagi–Harada syndrome. Retina 15:475–479PubMed Rutzen AR, Ortega-Larrocea G, Frambach DA, Rao NA (1995) Macular edema in chronic Vogt–Koyanagi–Harada syndrome. Retina 15:475–479PubMed
16.
go back to reference Wallyn RH, Hilton GF (1979) Subretinal fibrosis in retinal detachment. Arch Ophthalmol 97:2128–2129PubMed Wallyn RH, Hilton GF (1979) Subretinal fibrosis in retinal detachment. Arch Ophthalmol 97:2128–2129PubMed
17.
go back to reference Moorthy RS, Rajeev B, Smith RE, Rao NA (1994) Incidence and management of cataracts in Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 118:197–204PubMed Moorthy RS, Rajeev B, Smith RE, Rao NA (1994) Incidence and management of cataracts in Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 118:197–204PubMed
18.
go back to reference Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G (1993) Incidence and management of glaucoma in Vogt–Koyanagi–Harada syndrome. Ophthalmology 100:613–618PubMed Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G (1993) Incidence and management of glaucoma in Vogt–Koyanagi–Harada syndrome. Ophthalmology 100:613–618PubMed
19.
go back to reference Hayasaka S, Okabe H, Takahashi J (1982) Systemic corticosteroid treatment in Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol 218:9–13PubMedCrossRef Hayasaka S, Okabe H, Takahashi J (1982) Systemic corticosteroid treatment in Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol 218:9–13PubMedCrossRef
20.
go back to reference Sasamoto Y, Ohno S, Matsuda H (1990) Studies on corticosteroid therapy in Vogt–Koyanagi–Harada disease. Ophthalmologica 201:162–167PubMedCrossRef Sasamoto Y, Ohno S, Matsuda H (1990) Studies on corticosteroid therapy in Vogt–Koyanagi–Harada disease. Ophthalmologica 201:162–167PubMedCrossRef
21.
go back to reference Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. (2001) Complications and prognostic factors in Vogt–Koyanagi–Harada disease. Am J Ophthalmol 131:599–606PubMedCrossRef Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. (2001) Complications and prognostic factors in Vogt–Koyanagi–Harada disease. Am J Ophthalmol 131:599–606PubMedCrossRef
22.
go back to reference Rubsamen RE, Gass JDM (1991) Vogt–Koyanagi–Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109:682–687PubMed Rubsamen RE, Gass JDM (1991) Vogt–Koyanagi–Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109:682–687PubMed
23.
go back to reference Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt–Koyanagi–Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240:878–882PubMed Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt–Koyanagi–Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240:878–882PubMed
Metadata
Title
Vogt–Koyanagi–Harada disease in Hispanic patients
Authors
Somsiri Sukavatcharin
Julie H. Tsai
Narsing A. Rao
Publication date
01-06-2007
Publisher
Kluwer Academic Publishers
Published in
International Ophthalmology / Issue 2-3/2007
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-006-9017-6

Other articles of this Issue 2-3/2007

International Ophthalmology 2-3/2007 Go to the issue